Press Releases Livzon Pharmaceutical Group Inc.

Equities

000513

CNE0000002Y8

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
40.62 ^CNY	-0.54%		+0.17%	+16.02%

05-14	Livzon Pharmaceutical Group Cancels Share Options	MT
05-14	Livzon Pharmaceutical Declares Final Dividend for 2023	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Livzon Pharmaceutical : Interim Report 2023	22/08/23	PU
Livzon Pharmaceutical : Articles of Association (December 2022)	07/12/22	PU
Livzon Pharmaceutical : Interim Report 2022	09/08/22	PU
Livzon Pharmaceutical : 2022 FIRST QUARTERLY REPORT	21/04/22	PU
Expert consensus: Livzon Antiviral Granules are recommended for mild and common infections of COVID-19	20/04/22	PU
Livzon Pharmaceutical : A Recombinant SARS-Cov-2 Fusion Protein Vaccine (V-01) developed and manufactured by Livzon has shown good protective effects against the Omicron variant in a phase III clinical booster trial	20/04/22	PU
Livzon Pharmaceutical : was recognized as the National Enterprise Technology Center with High Scores	20/04/22	PU
Livzon Pharmaceutical : Rapid Test for 2019-nCoV-2 Antigen (Lateral Flow) approved by China NMPA.	20/04/22	PU
V-01 as a Sequential Booster Can Produce Good Protection against Omicron ---- Latest Phase III Data of COVID-19 Vaccine by Livzon Pharma	18/02/22	AQ
Livzon Pharmaceutical : POLL RESULTS OF THE 2021 THIRD EXTRAORDINARY GENERAL MEETING HELD ON THURSDAY, 29 JULY 2021	29/07/21	PU
Livzon Pharmaceutical : ANNOUNCEMENT ON PROGRESS OF THE REORGANIZATION	12/05/21	PU
Livzon Pharmaceutical : CANCELLATION OF THE REPURCHASED H SHARES	06/05/21	PU
Livzon Pharmaceutical : VOLUNTARY ANNOUNCEMENT LAUNCH OF FUTURES HEDGING ACTIVITIES BY CONTROLLING SUBSIDIARIES	06/05/21	PU
Livzon Pharmaceutical : POLL RESULTS OF THE 2021 SECOND EXTRAORDINARY GENERAL MEETING HELD ON THURSDAY, 6 MAY 2021	06/05/21	PU
Livzon Pharmaceutical : VOLUNTARY ANNOUNCEMENT UPDATE ANNOUNCEMENT ON ACQUISITION OF 40.00% EQUITY INTEREST IN TIANJIN TONGRENTANG	27/04/21	PU
Livzon Pharmaceutical : CIRCULAR OF THE ANNUAL GENERAL MEETING FOR THE YEAR 2020	23/04/21	PU
Livzon Pharmaceutical : PROPOSED COMPANY'S PROVISION OF FINANCING GUARANTEES TO CONTROLLING SUBSIDIARY LIVZON MAB	15/04/21	PU
Livzon Pharmaceutical : PROXY FORM FOR THE 2021 FIRST CLASS MEETING OF H SHAREHOLDERS TO BE HELD ON THURSDAY, 20 MAY 2021	15/04/21	PU
Livzon Pharmaceutical : NOTICE OF THE 2021 FIRST CLASS MEETING OF H SHAREHOLDERS	15/04/21	PU
Livzon Pharmaceutical : NOTICE OF THE ANNUAL GENERAL MEETING FOR THE YEAR 2020	15/04/21	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Livzon Pharmaceutical Group Inc.

Equities

000513

CNE0000002Y8

Press Releases

Filters